These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


154 related items for PubMed ID: 3416927

  • 21. Characterization of the central sympathoinhibitory action of ketanserin.
    McCall RB, Harris LT.
    J Pharmacol Exp Ther; 1987 May; 241(2):736-40. PubMed ID: 3572820
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Renal vascular and sympathetic nerve responses to hypotension induced by platelet-activating factor in anesthetized dogs.
    Matsuda Y, Shibamoto T, Hayashi T, Saeki Y, Yamaguchi Y, Tanaka S, Koyama S.
    Eur J Pharmacol; 1993 Dec 21; 250(3):341-7. PubMed ID: 8112393
    [Abstract] [Full Text] [Related]

  • 24. Differential effects of captopril and nicardipine on baroreflex control of sympathetic nerve activity and heart rate in renal hypertension.
    Kumagai H, Suzuki H, Matsumura Y, Ryuzaki M, Saruta T.
    J Hypertens; 1992 Dec 21; 10(12):1485-91. PubMed ID: 1338079
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Adenosine triphosphate attenuates renal sympathetic nerve activity through left ventricular chemosensitive receptors.
    Taneyama C, Benson KT, Hild PG, Goto H.
    J Pharmacol Exp Ther; 1997 Feb 21; 280(2):570-5. PubMed ID: 9023265
    [Abstract] [Full Text] [Related]

  • 27. Effects of alinidine (ST 567) on baroreceptor-heart rate reflexes and its interactions with clonidine on the baroreflex and on the sympathetic terminals of the isolated atrium.
    Heinzow BG, Angus JA, Korner PI.
    Eur J Pharmacol; 1982 Oct 22; 84(3-4):177-87. PubMed ID: 7173318
    [Abstract] [Full Text] [Related]

  • 28. Sympathetic activation and tachycardia in lipopolysaccharide treated rats are temporally correlated and unrelated to the baroreflex.
    Vayssettes-Courchay C, Bouysset F, Verbeuren TJ.
    Auton Neurosci; 2005 Jun 15; 120(1-2):35-45. PubMed ID: 15996623
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Evidence for a central depressor action of postsynaptic alpha 1-adrenergic receptor antagonists.
    McCall RB, Humphrey SJ.
    J Auton Nerv Syst; 1981 Feb 15; 3(1):9-23. PubMed ID: 6114972
    [Abstract] [Full Text] [Related]

  • 31. Activation of vagal depressor reflexes by atriopeptins inhibits renal sympathetic nerve activity.
    Thorén P, Mark AL, Morgan DA, O'Neill TP, Needleman P, Brody MJ.
    Am J Physiol; 1986 Dec 15; 251(6 Pt 2):H1252-9. PubMed ID: 2947476
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pharmacological properties of (N-dicyclopropylmethyl) amino-2-oxazoline (S 3341), an alpha-2 adrenoceptor agonist.
    Laubie M, Poignant JC, Scuvée-Moreau J, Dabire H, Dresse A, Schmitt H.
    J Pharmacol; 1985 Dec 15; 16(3):259-78. PubMed ID: 2866274
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cardiovascular effects of B-HT 958, an alpha-adrenoceptor agonist with a high pre/postsynaptic activity ratio.
    Kobinger W, Pichler L.
    Eur J Pharmacol; 1984 Jan 13; 97(1-2):67-73. PubMed ID: 6141948
    [Abstract] [Full Text] [Related]

  • 37. Prazosin depression of baroreflex function in hypertensive man.
    Sasso EH, O'Connor DT.
    Eur J Clin Pharmacol; 1982 Jan 13; 22(1):7-14. PubMed ID: 7047170
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.